[{"Assets_0_Q2_USD":205156000.0,"CommonStockSharesOutstanding_0_Q2_shares":16945069.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-7424000.0,"NetIncomeLoss_1_Q2_USD":-5348000.0,"NetIncomeLoss_2_Q2_USD":-9459000.0,"StockholdersEquity_0_Q2_USD":198290000.0,"Ticker":"KRYS","CIK":"1711279","name":"KRYSTAL BIOTECH, INC.","OfficialName":"Krystal Biotech Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1834745088.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190805"}]